Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Lemoine

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
BMJ Open|November 19, 2020
Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C)Delphine Rapoud, Catherine Quillet, Khue Pham Minh, et al.
Scientific Reports|May 3, 2024
Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)Karine Lacombe, Raoul Moh, Corine Chazallon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM StudyMaud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)Alexandra M Famiglietti, Sainabou Drammeh, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2024
Availability of point-of-care HBV tests in resource-limited settingsDaryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
Journal of Viral Hepatitis|September 29, 2025
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in VietnamDidier Laureillard, Nguyen Thanh Binh, Vu Hai Vinh, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional studyNicolas Minier, Alice Nanelin Guingané, Edith Okeke, et al.
BMC Medicine|July 4, 2023
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workersYasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
BMJ Open|November 19, 2020
Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C)Delphine Rapoud, Catherine Quillet, Khue Pham Minh, et al.
Scientific Reports|May 3, 2024
Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)Karine Lacombe, Raoul Moh, Corine Chazallon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2018
Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM StudyMaud Lemoine, Lambert Assoumou, Stephane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)Alexandra M Famiglietti, Sainabou Drammeh, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2024
Availability of point-of-care HBV tests in resource-limited settingsDaryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
Journal of Viral Hepatitis|September 29, 2025
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in VietnamDidier Laureillard, Nguyen Thanh Binh, Vu Hai Vinh, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional studyNicolas Minier, Alice Nanelin Guingané, Edith Okeke, et al.
BMC Medicine|July 4, 2023
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workersYasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, et al.
Pageof 16